MedPlus Health Services Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	3/31/2021	3/31/2022	3/31/2024	3/31/2026	3/31/2027	3/31/2028
Revenue % change YoY	₹30.50B N/A	₹37.55B 23.09%	₹56.24B 49.78%	Avg: ₹80.53B Low: ₹78.51B High: ₹83.23B avg. 43.17%	Avg: ₹92.47B Low: ₹90.27B High: ₹95.05B avg. 14.83%	Avg: ₹105.34B Low: ₹102.83B High: ₹108.28B avg. 13.91%
Net Income % change YoY	₹638.58M N/A	₹958.02M 50.02%	₹654.73M -31.65%	Avg: ₹1.91B Low: ₹1.64B High: ₹2.16B avg. 192.00%	Avg: ₹2.57B Low: ₹2.10B High: ₹3.16B avg. 34.51%	Avg: ₹0 Low: ₹0 High: ₹0 avg. -100%
EBITDA % change YoY	₹2.38B N/A	₹3.00B 25.95%	₹3.94B 31.34%	Avg: ₹5.67B Low: ₹5.53B High: ₹5.86B avg. 43.96%	Avg: ₹6.51B Low: ₹6.35B High: ₹6.69B avg. 14.83%	Avg: ₹7.42B Low: ₹7.24B High: ₹7.62B avg. 13.91%
EPS % change YoY	$6.26 N/A	$15.97 155.11%	$5.48 -65.68%	Avg: $16.01 Low: $13.7 High: $18 avg. 192.06%	Avg: $21.53 Low: $17.5 High: $26.3 avg. 34.54%	Avg: $0 Low: $0 High: $0 avg. -100%
Operating Expenses % change YoY	₹4.97B N/A	₹6.16B 24.01%	₹6.50B 5.58%	Avg: ₹1.81B Low: ₹1.77B High: ₹1.88B avg. -72.04%	Avg: ₹2.08B Low: ₹2.03B High: ₹2.14B avg. 14.83%	Avg: ₹2.38B Low: ₹2.32B High: ₹2.44B avg. 13.91%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 75.50% in 2026-2028.

We have gathered data from 6 analysts. Their low estimate is 1.64B, average is 1.91B and high is 2.16B.

Wall Street analysts forecast annual average revenue growth of 23.97% in 2026-2028.

We have gathered data from 6 analysts. Their low revenue estimate is ₹78.51B, average is ₹80.53B and high is ₹83.23B.

Wall Street analysts forecast annual average earnings growth of 75.53% in 2026-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is $13.7, average is $16.01 and high is ₹18.